Skip to main content
Premium Trial:

Request an Annual Quote

Patrice Hugo, David Weber

Premium
MDS Pharma Services has named Patrice Hugo as vice president of scientific affairs for its global central lab network, the company announced this week.
 
In this role, Hugo will lead the development of biomarkers and assays to enhance clinical development productivity from Phases I through IV.
 
Hugo was previously executive vice president of research and development at Caprion Proteomics. From 1997 to 2003, he was vice president of scientific research and then chief scientific officer at Procrea BioSciences. Prior to Procrea, Hugo worked for the Institut de Recherches Cliniques de Montreal (Montreal Institute of Clinical Research).
 


 
Fluorotechnics has named former GE Healthcare Biosciences President David Weber as non-executive director.
 
Weber was most recently chief executive officer and president of Eksigent Technologies. Prior to Ekisigent, he was the vice president of global marketing and business development for Stratagene.
 
Weber has also held senior executive roles with Chemdex, Amersham Biosciences, and Pharmacia Biotech.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.